CD274 and lung adenocarcinoma: Adam J. Schoenfeld and colleagues investigated PD‐L1 expression in 1586 lung adenocarcinoma patients,10 categorizing them into high (≥50%), low (1%–49%), and negative (<1%) expression groups, with a focus on discerning differences between the high and negative expression groups.